NCT04710329View on ClinicalTrials.gov

High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

January 16, 2021

Primary Completion Date

January 25, 2021

Study Completion Date

February 10, 2021

Conditions
Respiratory Distress Syndrome, AdultCovid19
Interventions
DRUG

Ascorbic acid

The daily administration of 6 grams of vitamin C intravenously in 4 equal doses every 6 hours occurred and the treatment lasted 96 hours. Vials containing 1.5 gr vitamin C were placed in 100 cc 5% dextrose and infused intravenously in 30-60 minutes. Prepared serum bottles and sets are wrapped with aluminum foil in order to protect them from sunlight.

Trial Locations (1)

34376

Sisli etfal training and resource hospital, Şişli

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT04710329 - High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients | Biotech Hunter | Biotech Hunter